HCPCS Level II › G
HCPCS Level II codes starting with G
2,011 codes, page 7 of 21. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| G2197 | Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user | Valid |
| G2198 | Documentation of medical reason(s) for not screening for unhealthy alcohol use using a systematic screening method (e.g., limited life expectancy, other medical reasons) through FY2026 | Terminated |
| G2199 | Patient not screened for unhealthy alcohol use using a systematic screening method | Valid |
| G2200 | Patient identified as an unhealthy alcohol user received brief counseling | Valid |
| G2201 | Documentation of medical reason(s) for not providing brief counseling (e.g., limited life expectancy, other medical reasons) through FY2026 | Terminated |
| G2202 | Patient did not receive brief counseling if identified as an unhealthy alcohol user | Valid |
| G2203 | Documentation of medical reason(s) for not providing brief counseling if identified as an unhealthy alcohol user (e.g., limited life expectancy, other medical reasons) through FY2026 | Terminated |
| G2204 | Patients between 45 and 85 years of age who received a screening colonoscopy during the performance period | Valid |
| G2205 | Patients with pregnancy during adjuvant treatment course | Valid |
| G2206 | Patient received adjuvant treatment course including both chemotherapy and her2-targeted therapy | Valid |
| G2207 | Reason for not administering adjuvant treatment course including both chemotherapy and her2-targeted therapy (e.g. poor performance status (ecog 3-4; karnofsky <=50), cardiac contraindications, insufficient renal function, insufficient hepatic function, other active or secondary cancer diagnoses, other medical contraindications, patients who died during initial treatment course or transferred during or after initial treatment course) | Valid |
| G2208 | Patient did not receive adjuvant treatment course including both chemotherapy and her2-targeted therapy | Valid |
| G2209 | Patient refused to participate | Valid |
| G2210 | Residual score for the neck impairment not measured because the patient did not complete the neck fs prom at initial evaluation and/or near discharge, reason not given | Valid |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to home or residence or office/outpatient evaluation and management service, new or established) | Valid |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | Valid |
| G2213 | Initiation of medication for the treatment of opioid use disorder in the emergency department setting, including assessment, referral to ongoing care, and arranging access to supportive services (list separately in addition to code for primary procedure) | Valid |
| G2214 | Initial or subsequent psychiatric collaborative care management, first 30 minutes in a month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional | Valid |
| G2215 | Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | Valid |
| G2216 | Take-home supply of injectable naloxone (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | Valid |
| G2250 | Remote assessment of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment | Valid |
| G2251 | Brief communication technology-based service, e.g. virtual check-in, by a qualified health care professional who cannot report evaluation and management services, provided to an established patient, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of clinical discussion | Valid |
| G2252 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | Valid |
| G3001 | Administration and supply of tositumomab, 450 mg through FY2026 | Terminated |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.) | Valid |
| G3003 | Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.) | Valid |
| G4000 | Dermatology mips specialty set | Valid |
| G4001 | Diagnostic radiology mips specialty set | Valid |
| G4002 | Electrophysiology cardiac specialist mips specialty set | Valid |
| G4003 | Emergency medicine mips specialty set | Valid |
| G4004 | Endocrinology mips specialty set | Valid |
| G4005 | Family medicine mips specialty set | Valid |
| G4006 | Gastro-enterology mips specialty set | Valid |
| G4007 | General surgery mips specialty set | Valid |
| G4008 | Geriatrics mips specialty set | Valid |
| G4009 | Hospitalists mips specialty set | Valid |
| G4010 | Infectious disease mips specialty set | Valid |
| G4011 | Internal medicine mips specialty set | Valid |
| G4012 | Interventional radiology mips specialty set | Valid |
| G4013 | Mental/behavioral and psychiatry mips specialty set | Valid |
| G4014 | Nephrology mips specialty set | Valid |
| G4015 | Neurology mips specialty set | Valid |
| G4016 | Neurosurgical mips specialty set | Valid |
| G4017 | Nutrition/dietician mips specialty set | Valid |
| G4018 | Obstetrics/gynecology mips specialty set | Valid |
| G4019 | Oncology/hematology mips specialty set | Valid |
| G4020 | Ophthalmology/optometry mips specialty set | Valid |
| G4021 | Orthopedic surgery mips specialty set | Valid |
| G4022 | Otolaryngology mips specialty set | Valid |
| G4023 | Pathology mips specialty set | Valid |
| G4024 | Pediatrics mips specialty set | Valid |
| G4025 | Physical medicine mips specialty set | Valid |
| G4026 | Physical therapy/occupational therapy mips specialty set | Valid |
| G4027 | Plastic surgery mips specialty set | Valid |
| G4028 | Podiatry mips specialty set | Valid |
| G4029 | Preventive medicine mips specialty set | Valid |
| G4030 | Pulmonology mips specialty set | Valid |
| G4031 | Radiation oncology mips specialty set | Valid |
| G4032 | Rheumatology mips specialty set | Valid |
| G4033 | Skilled nursing facility mips specialty set | Valid |
| G4034 | Speech language pathology mips specialty set | Valid |
| G4035 | Thoracic surgery mips specialty set | Valid |
| G4036 | Urgent care mips specialty set | Valid |
| G4037 | Urology mips specialty set | Valid |
| G4038 | Vascular surgery mips specialty set | Valid |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields through FY2026 | Terminated |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy through FY2026 | Terminated |
| G6003 | Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: up to 5 mev through FY2026 | Terminated |
| G6004 | Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 6-10 mev through FY2026 | Terminated |
| G6005 | Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 11-19 mev through FY2026 | Terminated |
| G6006 | Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 20 mev or greater through FY2026 | Terminated |
| G6007 | Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: up to 5 mev through FY2026 | Terminated |
| G6008 | Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 6-10 mev through FY2026 | Terminated |
| G6009 | Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 11-19 mev through FY2026 | Terminated |
| G6010 | Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 20 mev or greater through FY2026 | Terminated |
| G6011 | Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; up to 5 mev through FY2026 | Terminated |
| G6012 | Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev through FY2026 | Terminated |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev through FY2026 | Terminated |
| G6014 | Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20 mev or greater through FY2026 | Terminated |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session through FY2026 | Terminated |
| G6016 | Compensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session through FY2026 | Terminated |
| G6017 | Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment through FY2026 | Terminated |
| G6018 | Ileoscopy, through stoma; with transendoscopic stent placement (includes predilation) through FY2026 | Terminated |
| G6019 | Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique through FY2026 | Terminated |
| G6020 | Colonoscopy through stoma; with transendoscopic stent placement (includes predilation) through FY2026 | Terminated |
| G6021 | Unlisted procedure, intestine through FY2026 | Terminated |
| G6022 | Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique through FY2026 | Terminated |
| G6023 | Sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation) through FY2026 | Terminated |
| G6024 | Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique through FY2026 | Terminated |
| G6025 | Colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation) through FY2026 | Terminated |
| G6027 | Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed through FY2026 | Terminated |
| G6028 | Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies) through FY2026 | Terminated |
| G6030 | Amitriptyline through FY2026 | Terminated |
| G6031 | Benzodiazepines through FY2026 | Terminated |
| G6032 | Desipramine through FY2026 | Terminated |
| G6034 | Doxepin through FY2026 | Terminated |
| G6035 | Gold through FY2026 | Terminated |
| G6036 | Assay of imipramine through FY2026 | Terminated |
| G6037 | Nortriptyline through FY2026 | Terminated |
| G6038 | Salicylate through FY2026 | Terminated |